INGN
INGN
NASDAQ · Health Care

Inogen Inc

$5.62
-0.13 (-2.26%)
As of Nov 14, 2:22 AM ET ·
Financial Highlights (FY 2026)
Revenue
340.81M
Net Income
-22,234,380
Gross Margin
44.2%
Profit Margin
-6.5%
Rev Growth
-2.6%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 44.2% 44.2% 60.6% 60.6%
Operating Margin -8.7% -7.8% 10.4% 11.9%
Profit Margin -6.5% -6.2% 11.5% 10.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 340.81M 349.87M 69.91M 61.94M
Gross Profit 150.77M 154.78M 42.38M 37.55M
Operating Income -29,514,084 -27,268,941 7.24M 7.40M
Net Income -22,234,380 -20,543,005 8.03M 6.76M
Gross Margin 44.2% 44.2% 60.6% 60.6%
Operating Margin -8.7% -7.8% 10.4% 11.9%
Profit Margin -6.5% -6.2% 11.5% 10.9%
Rev Growth -2.6% -2.6% +4.1% -5.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 9.00M 9.23M
Total Equity — — 58.44M 60.45M
D/E Ratio — — 0.15 0.15
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -24,717,579 -24,106,046 11.00M 10.83M
Free Cash Flow — — 6.40M 6.40M